Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Eclinicalmedicine|October 31, 2022
Effectiveness of primary care psychological therapy services for the treatment of depression and anxiety in people living with dementia: Evidence from national healthcare records in EnglandGeorgia Bell, Celine El Baou, Rob Saunders, et al.
Journal of Psychiatric Research|May 2, 2022
Salivary cortisol in longitudinal associations between affective symptoms and midlife cognitive function: A British birth cohort studyAmber John, Roopal Desai, Rob Saunders, et al.
The Lancet. Healthy Longevity|December 12, 2022
Associations between psychological intervention for anxiety disorders and risk of dementia: a prospective cohort study using national health-care records data in EnglandJosh Stott, Rob Saunders, Roopal Desai, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 8, 2024
Predictors of primary care psychological therapy outcomes for depression and anxiety in people living with dementia: evidence from national healthcare records in EnglandGeorgia Bell, Celine El Baou, Rob Saunders, et al.
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.
International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.
Lancet (London, England)|October 24, 2021
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trialSube Banerjee, Juliet High, Susan Stirling, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2012
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trialRenee Romeo, Martin Knapp, Jennifer Hellier, et al.
Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Pageof 2